Tell us about your search experience on the TGA website - complete our short survey
Acalabrutinib receives TGA approval for CLL and SLL cancers
Published
Related content
- Provisional application receives approval through the first international collaborative review initiative between TGA, FDA and HCInternational Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab
- International Work-sharing Initiative - Abemaciclib (Verzenio)Second candidate in international work-share initiative
- International work-sharing initiative - Baloxavir marboxil (Xofluza)Xofluza approved as part of an international work-sharing initiative between the TGA, Health Canada and Swissmedic